information on the rationale behind the developed methods and explanations on the differences with other evaluation methods. In page 19 line 8 it is explained that for determination of convergent validity " further screening methods assessing the same type of physical exposures" will be used. Which methods will be used? These methods could also be used as keywords, so that users of these methods may become aware of this validation study.
REVIEWER
Florentino Serranheira National School of Public Health Universidade NOVA de Lisboa Portugal REVIEW RETURNED 16-Feb-2017 GENERAL COMMENTS This is a well-written protocol. Nevertheless, it tries something that could perhaps not be possible: standardise workplace biomechanical risk assessment methods.
Previously risk assessment studies at the same workplace found score (risk) divergences between methods. Methods were conceived for a particular workplace or workplaces and should never be used as a "kit" for all workplaces. Methods only evaluate the listed variables (risk factors) and frequently don't integrate the worker; they use a normalized men worker, younger, without health problems, and fully integrated in the society that comes from a statistical approach. WRMSD risk assessment tools should considerer individual risk assessment contributes to produce more consistent risk results.
Still, trying to have screening methods that could be used for anyone (without enough occupational, safety, and ergonomics information and training) at workplaces is also a mistake. Methods should be criteriously selected accordingly to the specific workplaces risk factors that were presents, and results (scores) should be critically interpreted together with individual occupational health records (that demands health and safety knowledge and could not be done by no matter whom).
The presented protocol intends to go further on WRMSD risk assessment and that is an understandable perspective facing the obtained results (not so goods) of most available methods and screening methods. However that should be carefully done. I believe that transversal studies have not enough power to produce valid results but I understand longitudinal studies are expensive and sometimes disruptive for the companies.
So I'll write some suggestions for this protocol:
1. BMJ Open is not an oriented Journal to Occupational Health or Ergonomics so I believe you should replace at abstract (and in the content) "physical exposures" by "biomechanical exposures"; 2. Introduction is well-written. procedure analysis" will be used? I believe it will be selected an industrial ergonomic work procedure analysis but will it be done by MTM or observing the real work? Results were from a MTM analysis or they come from the field, from the observed workers at their workplaces? ii. "application of the KIMs" is supported by previous study; we hope they have valid results; iii. "health outcomes" by interview is well documented; iv. "medical assessment" by SALTSA with trained physicians is also well documented; d. Statistical approach is strongly supported but:
i. "power for criterion validity" is done by a not well structured increasing system ( 
VERSION 1 -AUTHOR RESPONSE
Answers to Reviewer 1 (Thomas Laeubli) 1) Language: Like the authors my native language is German and I can easily understand the writing. I fear that for English speaking persons some expressions will be difficult to understand and might be misleading. Therefore, I suggest that the manuscript should be checked by a person with English as native language. Answer: The manuscript is checked by a native speaking person.
2) Missing information:
a. The authors provide Strobe 2007 to check for the completeness of the study but unfortunately do not precisely describe the variables (Item * 7). This information need to be presented in detail! Answer: We implemented a Table including a description of outcomes, exposures, predictors and potential confounders, see Table 3 , page 20.
b. More extended description of KIMs are recommended: It would be helpful to have detailed descriptions of all of the evaluated Key Indicator Methods (KIMs). Information on the "combined KIM" is completely missing. Answer: The main items considered in the revised and newly developed Key Indicator Methods are given in Table 1 and 2. The authors do understand the request of the reviewer to provide the drafts of the methods within the study protocol. But, we intend to publish only the final validated versions of the methods. We assure that the development of the methods was fixed at the beginning of the validation study. Changes between the fixed versions of the methods used for validation and the final versions will be highlighted. Remarks regarding this approach are already included in the draft in section "Timeframe of the study and dissemination of results" (page 25, lines 16-26). Further implemented on page 7, lines 20-25: "The "combined KIM" will be developed during the study based on the Key Indicators of the six KIMs.
Different mathematical models will be tested and enhanced iteratively. As this method is not fixed at the beginning of the validation study, we will only be able to disseminate a draft of a combined method and not a fully validated method at the end of this project." . 1998, 41:1290-311) . I am listing these examples because I expect to find more information on the rationale behind the developed methods and explanations on the differences with other evaluation methods. In page 19 line 8 it is explained that for determination of convergent validity "further screening methods assessing the same type of physical exposures" will be used. Which methods will be used? These methods could also be used as keywords, so that users of these methods may become aware of this validation study. We added the following (page 9, lines 24-27): No specific skills will be required for this tests, but the users will get a standardised introduction in the methods. The content of this introduction will be used later as framework for a guideline which will be disseminated with the method.
b. "Research goals" (RG3) intend to reach convergent validity with other screening methods but didn't say nothing about those screening methods; be sure other methods were designed for similar workplaces; Answer: Please see our answer to Reviewer 1, No. 2a
c. "Instruments and Methods" refers to other instruments and methods used by several authors: i. for instance what "ergonomic work procedure analysis" will be used? I believe it will be selected an industrial ergonomic work procedure analysis but will it be done by MTM or observing the real work? Results were from a MTM analysis or they come from the field, from the observed workers at their workplaces? Answer: The "ergonomic work procedure analysis" defines an a priori defined set of items of a complex workplace analysis. Results are recorded in a large modular document for a detailed description of the work tasks and the workplace. The analysis includes different ergonomic aspects (e.g. body posture, hand arm force, weight of load) which are needed to complete the KIMs and the alternative screening methods. The results are also used for the assessment of the convergent validity. We modified our description about this topic in the manuscript, see page 11, lines 11-14).
ii. "application of the KIMs" is supported by previous study; we hope they have valid results; Answer: No answer needed.
iii. "health outcomes" by interview is well documented; Answer: Thanks.
iv. "medical assessment" by SALTSA with trained physicians is also well documented; Answer: Thanks.
d. Statistical approach is strongly supported but: i. "power for criterion validity" is done by a not well structured increasing system (table 3 "increased", "at least double", at least triple"???), that seams poor for the objectives; Answer: We do not agree with the reviewer in this point. Considering the relatively high general prevalence of symptoms in the musculoskeletal system, the given criteria of the expected increase of the prevalence of symptoms describe significant increases compared to the reference group. The criteria "7-day prevalence significantly increased (at least triple)" for physical workloads in risk category 4 "high exposure level" means, that the prevalence of symptoms (for example symptoms in the hand/wrist region) is statistically (!) significant tripled compared to the prevalence in the reference group (a prevalence ratio of at least 3 with p<.05). The given criteria are based on results of previous studies. They reflect the expected contrast between the exposures and a dose-response relationship from the reference group to the high exposure group.
ii. "prevalence of tentative diagnoses" are expected low! Why? If the SALTSA (WRMSD symptoms and signs) were positives there are a presumption of a MSD!?!? Answer: We expect that the medical examination could only assign tentative diagnosis in the subgroup of subjects with symptoms in the musculoskeletal system. Therefore, the number of subjects with tentative diagnoses will be lower than the number of subjects with (selfreported) symptoms. The probability to detect subjects for example with complaints in the wrist is expected to be higher than the subjects with a carpal tunnel syndrome. The study is powered to detect differences in the prevalence of symptoms. The study is not sufficient to detect differences in the prevalence of diagnoses between the exposure levels considering the generally lower prevalence of diagnoses. 3) Spell out MEGAPHYS in abstract. Answer: The full name of the abbreviation MEGAPHYS is now given in the abstract (page 2, lines 16-17).
4) Currently, the research goals presented in page 8 looks like more or less study hypothesis. I suggest either to change Research goals to research hypothesis or revise the text (RG1-RG4). Answer: We decided to change "research goals" to "working hypotheses", as we think this is more suitable for a study protocol.
5) A lot of abbreviation used in the study makes it difficult to understand.
Answer: We inserted a list of abbreviations at the end of the manuscript to get a better overview, see page 27, lines 6-29.
VERSION 2 -REVIEW

REVIEWER
Florentino Serranheira Escola Nacional de Saúde Pública Universidade NOVA de Lisboa Portugal REVIEW RETURNED 08-May-2017
GENERAL COMMENTS
Thank you for reviewing your paper accordingly to our comments and suggestions. The final paper seams appropriate to publish in this journal and adds knowledge to this difficult area of selecting and identifying accuracy of WRMSD risk assessment methods.
